skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines fezolinetantQuestion & answer

fezolinetant · Medicine question

Which receptor does fezolinetant block?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Fezolinetant selectively blocks the neurokinin 3 (NK3) receptor.

Sources for this answer

Veoza 45 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated 27 April 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

fezolinetant

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about fezolinetant

Do Veoza (fezolinetant) 45 mg film-coated tablets contain mannitol?Does fezolinetant affect the ability to drive or use machines?Is concomitant use of fezolinetant with oestrogen hormone replacement therapy, excluding local vaginal preparations, recommended?What do Veoza (fezolinetant) 45 mg film-coated tablets look like?What were the most frequent adverse reactions reported with fezolinetant 45 mg?Why is fezolinetant not recommended for women with severe renal impairment or end-stage renal disease?

Read the fezolinetant guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX